Department of Medicinal Chemistry, Faculty of Pharmacy and Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Sci Rep. 2023 May 15;13(1):7819. doi: 10.1038/s41598-023-35140-5.
New series of thioquinoline structures bearing phenylacetamide 9a-p were designed, synthesized and the structure of all derivatives was confirmed using different spectroscopic techniques including FTIR, H-NMR, C-NMR, ESI-MS and elemental analysis. Next, the α-glucosidase inhibitory activities of derivatives were also determined and all the synthesized compounds (IC = 14.0 ± 0.6-373.85 ± 0.8 μM) were more potent than standard inhibitors acarbose (IC = 752.0 ± 2.0 μM) against α-glucosidase. Structure-activity relationships (SARs) were rationalized by analyzing the substituents effects and it was shown that mostly, electron-donating groups at the R position are more favorable compared to the electron-withdrawing group. Kinetic studies of the most potent derivative, 9m, carrying 2,6-dimethylphenyl exhibited a competitive mode of inhibition with K value of 18.0 µM. Furthermore, based on the molecular dynamic studies, compound 9m depicted noticeable interactions with the α-glucosidase active site via several H-bound, hydrophobic and hydrophilic interactions. These interactions cause interfering catalytic potential which significantly decreased the α-glucosidase activity.
设计、合成了一系列带有苯乙酰胺 9a-p 的噻吩并喹啉结构,采用傅里叶变换红外光谱(FTIR)、氢核磁共振(H-NMR)、碳核磁共振(C-NMR)、电喷雾质谱(ESI-MS)和元素分析等不同光谱技术对所有衍生物的结构进行了确认。接着,还测定了衍生物的α-葡萄糖苷酶抑制活性,所有合成的化合物(IC = 14.0 ± 0.6-373.85 ± 0.8 μM)对α-葡萄糖苷酶的抑制活性均强于标准抑制剂阿卡波糖(IC = 752.0 ± 2.0 μM)。通过分析取代基效应,对构效关系(SAR)进行了合理化解释,结果表明,与吸电子基团相比,R 位上的供电子基团通常更为有利。对具有最强抑制活性的衍生物 9m(带有 2,6-二甲基苯基)进行的动力学研究表明,其抑制模式为竞争性,K 值为 18.0 μM。此外,基于分子动力学研究,化合物 9m 通过氢键、疏水性和亲水性相互作用与α-葡萄糖苷酶的活性位点发生了显著相互作用。这些相互作用会干扰催化潜力,从而显著降低α-葡萄糖苷酶的活性。